Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent (Q33777249)

29 July 2017

1 reference

title

Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent (English)

1 reference

29 July 2017

1 reference

Kodama I

1

1 reference

29 July 2017

Kamiya K

series ordinal

2

1 reference

29 July 2017

Toyama J

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

84

1 reference

29 July 2017

issue

9A

1 reference

29 July 2017

page(s)

20R-28R

1 reference

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Controlling cardiac arrhythmias by lengthening repolarization: historical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Expanding indications for the use of Class III agents in patients at high risk for sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Antiarrhythmic drug therapy for ventricular arrhythmias: current perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone and post-MI patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone: Historical development and pharmacologic profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Cellular electropharmacology of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

The historical development, cellular electrophysiology and pharmacology of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone blocks inactivated cardiac sodium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Resting, and rate-dependent depression of Vmax of guinea-pig ventricular action potentials by amiodarone and desethylamiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Two types of sodium channel block by class-I antiarrhythmic drugs studied by using Vmax of action potential in single ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Voltage- and use-dependent modulation of calcium channel current in guinea pig ventricular cells by amiodarone and des-oxo-amiodarone

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Evidences of antagonism between amiodarone and triiodothyronine on the K+ channel activities of cultured rat cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Electrophysiologic effects of desethylamiodarone, an active metabolite of amiodarone: comparison with amiodarone during chronic administration in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Electropharmacology of amiodarone: absence of relationship to serum, myocardial, and cardiac sarcolemmal membrane drug concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

In vivo effects of amiodarone on cardiac beta-adrenoceptor density and heart rate require thyroid hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Antagonism between T3 and amiodarone on the contractility and the density of beta-adrenoceptors of chicken cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone alters thyroxine transfer and distribution in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Decreased transport of thyroxine (T4), 3,3',5-triiodothyronine (T3) and 3,3',5'-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone and thyroid hormone action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone α1-receptor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Does amiodarone affect heart rate by inhibiting the intracellular generation of triiodothyronine from thyroxine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

The effects of amiodarone on the electrocardiogram of the guinea-pig are not explained by interaction with thyroid hormone metabolism alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Effects of Amiodarone and Bepridil on Ventricular Depolarization and Repolarizationa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Vesnarinone prolongs action potential duration without reverse frequency dependence in rabbit ventricular muscle by blocking the delayed rectifier K+ current

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

Differential Effects of Amiodarone and Desethylamiodarone on Calcium Antagonist Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Acute and chronic effects of amiodarone on mammalian ventricular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900698-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(99)00698-0

1 reference

29 July 2017

1 reference